TK

Teshu Kumari

Active Director Director DIN 07219195
DIN 07219195 First appointment Jun 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Teshu Kumari

Data last updated:

Teshu Kumari is a Director at Oarvi Pharma Private Limited (since 2015). The company operates in Healthcare. Oarvi Pharma Private Limited reported revenue of ₹1.51 Cr (FY 2025).

DIN 07219195
Primary Designation Director
Industry Healthcare
First Appointment 26 Jun 2015
Oldest Company Age 14 yrs
Largest company Oarvi Pharma Private Limited · ₹1.51 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oarvi Pharma Private Limited U85190JH2012PTC000197
Director26 Jun 20152012₹1.51 Cr (FY 2025)Active

Board colleagues of Teshu Kumari

NameDINCompanyDesignation
Rahul Kumar03566092Oarvi Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oarvi Pharma Private Limited
Premium access

Shareholding and investment profile for Teshu Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Teshu Kumari

Teshu Kumari currently holds 1 directorship: Oarvi Pharma Private Limited (Director, since 26 Jun 2015, revenue ₹1.51 Cr (FY 2025)).

Teshu Kumari was first appointed on 26 Jun 2015 as Director at Oarvi Pharma Private Limited.

The current boards of Teshu Kumari's companies include Rahul Kumar (Oarvi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available